H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs NYU Grossman School of Medicine

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
NYU Grossman School of Medicine
NYRank #FEIN 13-5562309

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPNYU Grossman School of Medicine
Total filings80,813711
Certified %98.23%77.36%
Denied %1.09%0.00%
Withdrawn %0.61%2.81%
Cert-withdrawn %0.07%19.83%
Rank#4
Active yearsFY2010–FY2026FY2020–FY2026
Worksite statePANY

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — NYU Grossman School of Medicine

DOL case-status mix.

Outcome breakdown: Certified 77.4%, Cert-withdrawn 19.8%, Withdrawn 2.8%
Outcome breakdown
OutcomeShare
Certified77.4%
Cert-withdrawn19.8%
Withdrawn2.8%
Certified77.4%
Cert-withdrawn19.8%
Withdrawn2.8%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
NYU Grossman School of Medicine
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY20130
FY20140
FY20150
FY20160
FY20170
FY20180
FY20190
FY20203
FY20216
FY20221
FY202384
FY2024257
FY2025221
FY2026139

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — NYU Grossman School of Medicine

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.